4.7 Review

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy

Journal

Publisher

MDPI
DOI: 10.3390/ijms20020317

Keywords

natural killer cell line; NK-92; chimeric antigen receptor; immunotherapy; tumor

Funding

  1. National Natural Science Foundation of China [81371669]
  2. Project of Science and Technology of Quanzhou of China [2016Z006]
  3. Major project of University and Industry Cooperation in Fujian Province of China [2018Y4009]
  4. Subsidized Project for Cultivating Postgraduates' Innovative Ability in Scientific Research of Huaqiao University [1601116007]

Ask authors/readers for more resources

Natural killer (NK) cells are innate immune cells that can be activated rapidly to target abnormal and virus-infected cells without prior sensitization. With significant advancements in cell biology technologies, many NK cell lines have been established. Among these cell lines, NK-92 cells are not only the most widely used but have also been approved for clinical applications. Additionally, chimeric antigen receptor-modified NK-92 cells (CAR-NK-92 cells) have shown strong antitumor effects. In this review, we summarize established human NK cell lines and their biological characteristics, and highlight the applications of NK-92 cells and CAR-NK-92 cells in tumor immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available